A minimally cytotoxic CD4 mimic as an HIV entry inhibitor-Reference-Cited by-同舟云学术

A minimally cytotoxic CD4 mimic as an HIV entry inhibitor

Published:2016-01 Issue:2 Volume:26 Page:397-400
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Mizuguchi Takaaki,Harada Shigeyoshi,Miura Tomoyuki,Ohashi Nami,Narumi Tetsuo,Mori Hiromi,Irahara Yu,Yamada Yuko,Nomura Wataru,Matsushita Shuzo,Yoshimura Kazuhisa,Tamamura Hirokazu

Funder

Japan Agency for Medical Research and Development

Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan

Japanese Ministry of Health, Labor, and Welfare

JSPS

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference31 articles.

1. The successes and failures of HIV drug discovery

2. A Low-Molecular-Weight Inhibitor against the Chemokine Receptor CXCR4: A Strong Anti-HIV Peptide T140

3. Pharmacophore identification of a specific CXCR4 inhibitor, T140, leads to development of effective anti-HIV agents with very high selectivity indexes

4. Molecular-Size Reduction of a Potent CXCR4-Chemokine Antagonist Using Orthogonal Combination of Conformation- and Sequence-Based Libraries

5. Stereoselective Synthesis of [l-Arg-l/d-3-(2-naphthyl)alanine]-Type (E)-Alkene Dipeptide Isosteres and Its Application to the Synthesis and Biological Evaluation of Pseudopeptide Analogues of the CXCR4 Antagonist FC131

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of Small-Molecule Anti-HIV-1 Agents Targeting HIV-1 Capsid Proteins;Chemical and Pharmaceutical Bulletin;2024-01-01

2. Characterization of a Novel CD4 Mimetic Compound YIR-821 against HIV-1 Clinical Isolates;Journal of Virology;2023-01-31

3. Low-molecular-weight anti-HIV-1 agents targeting HIV-1 capsid proteins;RSC Advances;2023

4. Hybrids of small CD4 mimics and gp41-related peptides as dual-target HIV entry inhibitors;Bioorganic & Medicinal Chemistry;2022-12

5. Analysis of HIV latent infection model with multiple infection stages and different drug classes;Journal of Biological Dynamics;2022-10-20